Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

Press releases published on August 11, 2026

Aug. 11, 2026

These Have the Market Hot Zone Catalysts and Setups

Indeterminate GlobeNewswire

Aug. 11, 2026

Refurbished Medical Devices Market to reach USD 42.43 Billion by 2035 at 9.15% CAGR

Indeterminate EIN Presswire

Aug. 11, 2026

What is beta ecdysterone bulk powder extracted from?

Indeterminate EIN Presswire

Aug. 11, 2026

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 11, 2026

Light Therapy Market to reach USD 1.74 Billion by 2035 at 4.72% CAGR

Indeterminate EIN Presswire

Aug. 11, 2026

Apollomics Announces $10 Million Private Placement Transaction

Indeterminate GlobeNewswire

Aug. 11, 2026

Stran & Company Reports $33.4 Million in Revenue and $0.6 Million in EBITDA for the Second Quarter of 2026

Indeterminate GlobeNewswire

Aug. 11, 2026

FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026

Indeterminate GlobeNewswire

Aug. 11, 2026

FocalTherics™ Announces Proposed Public Offering of American Depositary Shares

Indeterminate GlobeNewswire

Aug. 11, 2026

Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)

Indeterminate GlobeNewswire

Aug. 11, 2026

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook

Indeterminate GlobeNewswire

Aug. 11, 2026

SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

Codexis Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

Aug. 11, 2026

Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 11, 2026

Spectral AI Announces 2026 Second Quarter Financial Results

Indeterminate GlobeNewswire

Aug. 11, 2026

MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program

Indeterminate GlobeNewswire